國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacogenomics in precision medici...

Cai, Weimin.

Pharmacogenomics in precision medicinefrom a perspective of ethnic differences /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacogenomics in precision medicineedited by Weimin Cai ... [et al.].
其他題名:	from a perspective of ethnic differences /
其他作者:	Cai, Weimin.
出版者:	Singapore :Springer Singapore :2020.
面頁冊數:	viii, 289 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Pharmacogenomics.
電子資源:	https://doi.org/10.1007/978-981-15-3895-7
ISBN:	9789811538957$q(electronic bk.)

Pharmacogenomics in precision medicinefrom a perspective of ethnic differences /
Pharmacogenomics in precision medicinefrom a perspective of ethnic differences /[electronic resource] :edited by Weimin Cai ... [et al.]. - Singapore :Springer Singapore :2020. - viii, 289 p. :ill., digital ;24 cm.

Chapter 1. Introduction and Principles of Pharmacogenomics and Precision medicine -- Chapter 2. Pharmacogenomics in Cardiovascular Diseases -- Chapter 3. Pharmacogenomics of Antitumor Chemotherapeutic Agents -- Chapter 4. Pharmacogenomics of Antitumor Targeted Agent and Immunotherapy -- Chapter 5. Pharmacogenomics of Immunosuppressant -- Chapter 6. Pharmacogenomics of Psychiatric drugs -- Chapter 7. Pharmacogenomics of Anti-Infective Agents -- Chapter 8. Pharmacogenomics of Antithrombotic drugs -- Chapter 9. Pharmacogenomics in Therapeutic Drug Monitoring -- Chapter 10. Pharmacomicrobiomics -- Chapter 11. Genotyping technology in Pharmacogenomics -- Chapter 12. The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics -- Chapter 13. Cost-effectiveness of pharmacogenetic-guided treatment -- Chapter 14. Application of pharmacogenomics in drug discovery and development -- Chapter 15. Barriers and Solutions in Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine.

This book provides an introduction to the principles of pharmacogenomics and precision medicine, followed by the pharmacogenomics aspects of major therapeutic areas such as cardiovascular disease, cancer, organ transplantation, psychiatry, infection, antithrombotic drugs. It also includes genotyping technology and therapeutic drug monitoring in Pharmacogenomics; ethical, Legal and Regulatory Issues; cost-effectiveness of pharmacogenetics-guided treatment; application of pharmacogenomics in drug discovery and development and clinical Implementation of Pharmacogenomics for Personalized Precision Medicine. The contributors of Pharmacogenomics in Precision Medicine come from a team of experts, including professors from academic institutions and practitioner from hospital. It will give an in-depth overview of the current state of pharmacogenomics in drug therapy for all health care professionals and graduate students in the era of precision medicine.

ISBN: 9789811538957$q(electronic bk.)

Standard No.: 10.1007/978-981-15-3895-7doiSubjects--Topical Terms:

211097
Pharmacogenomics.

LC Class. No.: RM301.3.G45 / P437 2020

Dewey Class. No.: 615.7

Pharmacogenomics in precision medicinefrom a perspective of ethnic differences /
LDR:02946nmm a2200325 a 4500 001 580300
003 DE-He213
005 20201023163629.0
006 m
007 cr
008 210105s2020
020 $a 9789811538957$q(electronic bk.)
020 $a 9789811538940$q(paper)
024 7 $a 10.1007/978-981-15-3895-7 $2 doi
035 $a 978-981-15-3895-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.3.G45 $b P437 2020
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.7 $2 23
090 $a RM301.3.G45 $b P536 2020
245 0 0 $a Pharmacogenomics in precision medicine $h [electronic resource] : $b from a perspective of ethnic differences / $c edited by Weimin Cai ... [et al.].
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a viii, 289 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Introduction and Principles of Pharmacogenomics and Precision medicine -- Chapter 2. Pharmacogenomics in Cardiovascular Diseases -- Chapter 3. Pharmacogenomics of Antitumor Chemotherapeutic Agents -- Chapter 4. Pharmacogenomics of Antitumor Targeted Agent and Immunotherapy -- Chapter 5. Pharmacogenomics of Immunosuppressant -- Chapter 6. Pharmacogenomics of Psychiatric drugs -- Chapter 7. Pharmacogenomics of Anti-Infective Agents -- Chapter 8. Pharmacogenomics of Antithrombotic drugs -- Chapter 9. Pharmacogenomics in Therapeutic Drug Monitoring -- Chapter 10. Pharmacomicrobiomics -- Chapter 11. Genotyping technology in Pharmacogenomics -- Chapter 12. The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics -- Chapter 13. Cost-effectiveness of pharmacogenetic-guided treatment -- Chapter 14. Application of pharmacogenomics in drug discovery and development -- Chapter 15. Barriers and Solutions in Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine.
520 $a This book provides an introduction to the principles of pharmacogenomics and precision medicine, followed by the pharmacogenomics aspects of major therapeutic areas such as cardiovascular disease, cancer, organ transplantation, psychiatry, infection, antithrombotic drugs. It also includes genotyping technology and therapeutic drug monitoring in Pharmacogenomics; ethical, Legal and Regulatory Issues; cost-effectiveness of pharmacogenetics-guided treatment; application of pharmacogenomics in drug discovery and development and clinical Implementation of Pharmacogenomics for Personalized Precision Medicine. The contributors of Pharmacogenomics in Precision Medicine come from a team of experts, including professors from academic institutions and practitioner from hospital. It will give an in-depth overview of the current state of pharmacogenomics in drug therapy for all health care professionals and graduate students in the era of precision medicine.
650 0 $a Pharmacogenomics. $3 211097
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Laboratory Medicine. $3 276727
650 2 4 $a Human Genetics. $3 273658
700 1 $a Cai, Weimin. $3 870122
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-15-3895-7
950 $a Biomedical and Life Sciences (Springer-11642)